Clinical Trial Update: A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma [Phase 1]

View source ↗

Summary

This Phase I study evaluating safety and tolerability in adults with lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: MedImmune LLC | Conditions: Lymphoma, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | Status: WITHDRAWN